U.S. orders 3.2 million doses of Novavax COVID vaccine

U.S. orders 3.2 million doses of Novavax COVID vaccine The U.S. government will get 3.2 million doses of COVID-19 vaccine developed by Novavax Inc once the shot has been authorized by the regulators, the Department of Health and Human Services (HHS) and the company said on Monday. Reuters Reuters

...

Novavax's shot, which is already available in over 40 countries, is a more traditional type of vaccine employing technology that has been used for decades to combat diseases like influenza.

Maryland-based Novavax is hoping to gain a foothold within the roughly 27 million U.S. adults who are yet to be vaccinated, particularly those who do not want to receive a vaccine like the Pfizer /BioNTech (22UAy.DE) or Moderna Inc (MRNA.O) shots, which are based on the groundbreaking messenger RNA (mRNA) technology. ...